Skip to content
Screener

Encompass Health Corporation EHC Cash & Equivalents

Cash & Equivalents at other companies

National Healthcare logo
National HealthcareNHC
$39.21M-64.7%
Addus HomeCare logo
Addus HomeCareADUS
$103.07M+6.3%
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
$182.3M-20.5%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
$15.27M+6.2%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$189.27M+165%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%

Other financials

Income statement

See full
Revenue$1.6B+9.0%
Operating income$151.9M+18.3%
Net income$194.5M+28.4%
EPS (diluted)$1.93+30.4%

Balance sheet

See full
Total debt$3.1B-1.1%
Total equity$2.5B+16.8%
Total assets$7.3B+10.1%

Cash flow

See full
Operating cash flow$313.1M+8.5%
CapEx$162.4M-0.4%
Free cash flow$150.7M+20.1%

Valuation

See full
Market cap$11B-6.4%
Enterprise value$13.96B-5.3%
P/E18.1×-4.4×
P/S1.8×-0.3×

Profitability

See full
Operating margin12.4%-1.5pp
Net margin10%+1.1pp
FCF margin7.7%+0.6pp

Returns & leverage

See full
Return on equity26%+0.7pp
Debt / equity1.2×-0.2×
Current ratio1.2×+0.1×

Where this comes from

Reported directly by Encompass Health Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Encompass Health Corporation’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 3:28 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000785161-26-000130
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Dividends paid on common stock(20.3)(18.0)
Distributions paid to noncontrolling interests of consolidated affiliates(57.8)(32.9)
Taxes paid on behalf of employees for shares withheld(30.9)(19.8)
Other, net(11.9)(7.6)
Net cash used in financing activities(102.5)(130.4)
Increase (decrease) in cash, cash equivalents, and restricted cash60.5(0.3)
Cash, cash equivalents, and restricted cash at beginning of period102.9123.1
Cash, cash equivalents, and restricted cash at end of period$163.4$122.8

Item 1.Financial Statements (Unaudited)

FAQ

What is Encompass Health Corporation's cash & equivalents?
Encompass Health Corporation (EHC) reported cash & equivalents of $163.4M in Q1 2026.
How has Encompass Health Corporation's cash & equivalents changed year-over-year?
Encompass Health Corporation's cash & equivalents increased by 33.1% year-over-year, from $122.8M to $163.4M.
What is the long-term trend for Encompass Health Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Encompass Health Corporation's cash & equivalents has grown at a -19.8% compound annual growth rate (CAGR), from $310.9M to $102.9M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Encompass Health Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude